People: Pfizer Inc (PFE)
21 Apr 2017
Dr. Mikael Dolsten, M.D., Ph.D., is President - Worldwide Research and Development of the Company. He was Senior Vice President; President of Worldwide Research and Development from May 2010 until December 2010. Senior Vice President; President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. He was a Private Equity Partner at Orbimed Advisors, LLC from January 2008 until June 2008. Director of Karyopharm Therapeutics Inc. Chairman of the Translational Advisory Board of Apple Tree Partners.
|Total Annual Compensation, USD||2,977,500|
|Restricted Stock Awards, USD||1,144,490|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||4,105,980|
|Fiscal Year Total, USD||8,227,970|